Bristol-Myers Squibb Aktie

Kaufen
Verkaufen
54,59 EUR +1,25 EUR +2,34 %
58,46 USD +1,66 USD +2,92 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 107,71 Mrd. EUR

KGV 13,29 Div. Rendite 4,50%

WKN 850501

ISIN US1101221083

Symbol BMY


Bristol-Myers Squibb Aktie Analyse

28.10.16 Bristol-Myers Squibb Hold Deutsche Bank AG
09.09.16 Bristol-Myers Squibb Equal weight Barclays Capital
23.05.16 Bristol-Myers Squibb Neutral J.J.B. Hilliard, W.L. Lyons, Inc.
29.04.16 Bristol-Myers Squibb Equal weight Barclays Capital
01.12.15 Bristol-Myers Squibb Equal weight Barclays Capital
02.07.14 Bristol-Myers Squibb Equal weight Barclays Capital
12.07.13 Bristol-Myers Squibb halten Jefferies & Company Inc.
10.12.12 Bristol-Myers Squibb neutral UBS AG
03.12.12 Bristol-Myers Squibb neutral Citigroup Corp.
02.08.12 Bristol-Myers Squibb neutral UBS AG
26.07.12 Bristol-Myers Squibb neutral UBS AG
20.07.12 Bristol-Myers Squibb neutral UBS AG
22.06.12 Bristol-Myers Squibb neutral Credit Suisse Group
27.10.11 Bristol-Myers Squibb neutral UBS AG
27.06.11 Bristol-Myers Squibb neutral UBS AG
27.06.11 Bristol-Myers Squibb neutral UBS AG
24.06.11 Bristol-Myers Squibb neutral Credit Suisse Group
23.06.11 Bristol-Myers Squibb neutral UBS AG
15.06.11 Bristol-Myers Squibb neutral UBS AG
12.05.11 Bristol-Myers Squibb neutral Goldman Sachs Group Inc.
31.03.11 Bristol-Myers Squibb hold Jefferies & Company Inc.
28.03.11 Bristol-Myers Squibb neutral Credit Suisse Group
22.03.11 Bristol-Myers Squibb neutral Credit Suisse Group
05.10.10 Bristol-Myers Squibb equal-weight Morgan Stanley
01.09.10 Bristol-Myers Squibb neutral UBS AG
30.04.10 Bristol-Myers Squibb halten Credit Suisse Group
13.04.10 Bristol-Myers Squibb halten Goldman Sachs Group Inc.
16.12.09 Bristol-Myers Squibb neutral UBS AG
07.12.09 Bristol-Myers Squibb neutral Credit Suisse Group
26.10.09 Bristol-Myers Squibb neutral Goldman Sachs Group Inc.
12.10.09 Bristol-Myers Squibb neutral Cowen and Company, LLC
31.08.09 Bristol-Myers Squibb equal-weight Morgan Stanley
24.07.09 Bristol-Myers Squibb neutral Credit Suisse Group
24.07.09 Bristol-Myers Squibb neutral Credit Suisse Group
03.04.09 Bristol-Myers Squibb market perform Sanford C. Bernstein and Co., Inc.
17.12.08 Bristol-Myers Squibb neutral Merrill Lynch & Co., Inc.
17.11.08 Bristol-Myers Squibb neutral Banc of America Securities LLC
18.07.08 Bristol-Myers Squibb hold Citigroup Corp.
25.06.08 Bristol-Myers Squibb neutral JP Morgan Chase & Co.
06.06.08 Bristol-Myers Squibb market perform Rodman & Renshaw, LLC
04.06.08 Bristol-Myers Squibb neutral Cowen and Company, LLC
30.05.08 Bristol-Myers Squibb hold ROTH Capital Partners, LLC
07.12.07 Bristol-Myers Squibb neutral Susquehanna Financial Group, LLLP
20.11.07 Bristol-Myers Squibb neutral Cowen and Company, LLC
19.11.07 Bristol-Myers Squibb neutral Cowen and Company, LLC
06.09.06 Bristol-Myers Squibb hold Deutsche Securities
04.09.06 Bristol-Myers Squibb neutral UBS
01.09.06 Bristol-Myers Squibb hold A.G. Edwards & Sons
01.09.06 Bristol-Myers Squibb Hold AG Edwards
01.09.06 Bristol-Myers Squibb Neutral UBS